Jan 13 (Reuters) - Proxy advisory firm Ownership Matters said on Monday it recommends that shareholders of Sigma Healthcare SIG.AX vote in favour of Chemist Warehouse's reverse takeover of the pharmaceutical company, citing significant shareholder value.
Sigma Healthcare will conduct a shareholder meeting on Jan. 29 to seek approval for the deal, which will create a $5.8 billion entity.
As part of the deal, which was announced in December 2023, Chemist Warehouse will buy Sigma for stock and A$700 million in cash, giving it a roughly 85% stake in the merged entity and a back door to list on the Australian stock exchange.
In early November, the Australian competition regulator cleared the deal after the companies made concessions to alleviate competition concerns.
Shares of Sigma Healthcare have surged more than 300% since the announcement of the deal. It was last down 1.2% at A$2.965.
(Reporting by John Biju in Bengaluru; Editing by Sonia Cheema)
((John.Biju@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。